Adenovirus and its Vector for Developing Vaccines against Biological Warfare Agents

PDF

Authors
  1. Wu, Q.
Corporate Authors
Defence R&D Canada - Suffield, Ralston ALTA (CAN)
Abstract
This memorandum reviews a new platform for the development of vaccines against biological warfare (BW) agents. The noted platform uses adenovirus as a vector to deliver DNA that encodes for key antigens of BW agents. Once inside the mammalian cell, this adenovirus vectored vaccine induces rapid immune responses. This memorandum describes the basic virology of adenovirus, methods used to modify adenovirus as vaccination vector, advantages of adenovirus vector for developing vaccines against BW agents such as Ebola and anthrax, and the potential obstacles, with proposed solutions, for the use of adenovirus vector.

Il y a un résumé en français ici.

Keywords
Vaccine development;adenovirus infection;adenovirus vector;biological warfare agent
Report Number
DRDC-SUFFIELD-TM-2004-249 — Technical Memorandum
Date of publication
01 Nov 2004
Number of Pages
40
DSTKIM No
CA025274
CANDIS No
522859
Format(s):
CD ROM

Permanent link

Document 1 of 1

Date modified: